NEW YORK (GenomeWeb News) – HairDx today said that it has signed up a distributor in the Dominican Republic for its genetic baldness tests.

The firm said that the Skin and Hair Transplant Institute of Santo Domingo will introduce the tests in the country. Terms of the agreement were not disclosed.

"The genetic tests made by HairDX … give important information about responsiveness to patients considering Finasteride treatment," Alba Reyes Sagiv, who runs the institute, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.